Matthew E. Voss

Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice

Laura A. Hancock, Corinne E. Hennessy, George M. Solomon et al. · Nature Communications · 2018 · 240 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α

Percy H. Carter, Peggy Scherle, Jodi A. Muckelbauer et al. · Proceedings of the National Academy of Sciences · 2001 · 140 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Design and synthesis of a protein .beta.-turn mimetic

Gary L. Olson, Matthew E. Voss, David E. Hill et al. · Journal of the American Chemical Society · 1990 · 87 citations

Life Sciences, Biochemistry, Molecular Biology +10

Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in Vivo

Chu‐Biao Xue, Matthew E. Voss, David J. Nelson et al. · Journal of Medicinal Chemistry · 2001 · 79 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists

Matthew E. Voss, Percy H. Carter, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7